891
Participants
Start Date
February 1, 2021
Primary Completion Date
August 30, 2021
Study Completion Date
October 1, 2021
COVID-19 vaccine hesitancy scale in rheumatic diseases
The instrument was developed by Freeman et al, prior to its application, translation, cultural adaptation, and validation were performed.
COVID-19 vaccine hesitancy associated factors
The instrument includes questions about the doctor-patient relationship, perception of the COVID-19 vaccine, perception of risk of COVID-19 infection, perception of the severity of the pandemic in Mexico, perception of the severity of their rheumatic disease, perception of the control of comorbidities, perception of the intensity of the immunosuppressive treatment, positioning of the patient towards vaccines for COVID-19
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City
National Institute of Medical Sciences and Nutrition, Salvador Zubiran
OTHER